NCT00131430View on ClinicalTrials.gov

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Obesity and Obesity-related Medical Conditions
Interventions
DRUG

taranabant

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00131430 - An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED) | Biotech Hunter | Biotech Hunter